Spermotrend is a natural based product manufactured by Catalysis Laboratories. Its composition contains different essential elements for spermatogenesis: selenium, zinc and fructose. In addition, it contains L-arginine, natural precursor of nitric oxide that favors vasodilation, and pygeum africanum extract with antioxidant, antiinflammatory, antiandrogenic and antiproliferative action. Its main action resides in the control of oxidative damage to the tissues of the male reproductive system, as well as the control of correct spermatogenesis. Given that sperm quality can be altered by oxidative stress and that male infertility affects more and more people, the prevention and management of this deterioration becomes increasingly important. Therefore, to evaluate Spermotrend as a new therapy for male infertility, the investigators are going to study the safety and efficacy of this treatment in this clinical trial. RESEARCH HYPOTHESIS The treatment with Spermotrend improves the parameters of the spermatogenesis. GENERAL OBJECTIVES To evaluate the effectiveness and the safety level of the natural Spermotrend product in the treatment of male infertility. SPECIFIC OBJECTIVES * Evaluate the increase in sperm motility and concentration. * Identify the improvement in the seminal fluid volume. * Identify the positive changes in the sperm morphology. * Determine how to maintain the semen analysis in a normal range. * Describe the adverse effects. SECONDARY OBJECTIVES * Identify the improvement in urinary symptoms related with benign prostatic hyperplasia. * Identify the improvement in varicocele.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sperm motility
Timeframe: 3 months
Sperm concentration
Timeframe: 3 months
Seminal fluid volume.
Timeframe: 3 months
Sperm morphology.
Timeframe: 3 months
Incidence of adverse events during the treatment with Spermotrend
Timeframe: 3 months